||||||||||anti-BCMA CAR T cells / Allife Medical Science and Technology New P1 trial, CAR T-Cell Therapy: Study of BCMA CAR-T in Multiple Myeloma (clinicaltrials.gov) - Jul 15, 2018 P1, N=20, Not yet recruiting, Sponsor: Allife Medical Science and Technology Co., Ltd.